IWA
EW icon

Inspirion Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Inspirion Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
+1,500
New +$126K 0.02% 184

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

Inspirion Wealth Advisors's EW Position: Q2 2026 in Review

Inspirion Wealth Advisors held its Edwards Lifesciences (EW) position steady in Q2 2026 at 15,236 shares worth $1.4M. The position accounts for 0.16% of the portfolio, ranked #60.

Inspirion Wealth Advisors first reported a position in EW in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.52M in Q4 2021. 186 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Inspirion Wealth Advisors held 15,236 shares of Edwards Lifesciences worth $1.4M as of Q2 2026.
  • Inspirion Wealth Advisors left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.16% of Inspirion Wealth Advisors's portfolio in Q2 2026, its #60 holding.
  • Inspirion Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 47 quarters since.
  • Inspirion Wealth Advisors's Edwards Lifesciences position peaked at $1.52M in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.